This article was written by Follow I am a young individual investor with a strong focus on long-term wealth creation. My investment strategy revolves...
This article was written by Follow I take a fundamentals-based approach to value investing.I disagree with the common misconception held by many investors that...
This article was written by Follow Equity Research Analyst with a broad career in the financial market, covered both Brazilian and global stocks. As...
Thesis We covered the BlackRock Flexible Income ETF (NYSEARCA:BINC) shortly after its inception almost a year ago. In our original piece, we described the...
Investment Thesis Sunoco LP Common Units (NYSE:SUN) has been on a bullish trajectory gaining about 64.12% over the last three years outperforming the S&P...
This week, we have three six new dividend increases, including dividend king Colgate-Palmolive! They extend their 61-year streak with a 4.2% increase. The average...
Investment Overview Elevance Health (NYSE:ELV) will announce its Q1 2024 earnings next Thursday, April 18th ahead of the market open. When I last covered...
Nektar Therapeutics (NASDAQ:NKTR) has an interesting drug in its pipeline, rezpegaldesleukin (rezpeg), that has the potential to treat inflammation in a new way. The...